Clinical trials
Phase 3 Glucose Intolerance trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2018 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis | 2 |
| Sanofi | 2 |
| Takeda | 2 |
| Woman's | 2 |
| Daiichi Sankyo | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| The University of Texas Health Science Center at San Antonio | 1 |
| Thomas J. Wang, MD | 1 |
| University of Pennsylvania | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucose Intolerance | 13 |
| Diabetes Mellitus, Type 2 | 8 |
| Prediabetic State | 3 |
| Diabetes Mellitus | 2 |
| Hyperglycemia | 2 |
| Cardiovascular Diseases | 1 |
| Diabetes, Gestational | 1 |
| Hypercholesterolemia | 1 |
| Hyperinsulinism | 1 |
| Hypersensitivity | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.